{"id":"dce04e2cf197","type":"article","url":"https://hartvaat.nl/2016/09/27/intensieve-glucoseregulatie-bij-hyperglycemisch-acs-langetermijnfollow-up-biomar/","title":"Intensieve glucoseregulatie bij hyperglycemisch ACS: langetermijnfollow-up BIOMArCS-2","title_en":"Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.","category":"algemeen","category_label":"Algemeen","professions":["cardioloog","internist"],"tags":["diabetes-en-hart","soul-trial"],"journal":"Circulation","doi":"10.1161/CIRCULATIONAHA.116.023480","source_url":"https://doi.org/10.1161/CIRCULATIONAHA.116.023480","authors":["Victor J van den Berg","Victor A W M Umans","Frank Stam","Maarten de Mulder","K Martijn Akkerhuis","Jan H Cornel","Isabella Kardys","Eric Boersma"],"significance":6,"published":"2016-09-27","source_date":"2016-09-27","image":"","kennis":["https://hartvaat.nl/kennis/cardiometabool/bloedsuikerdoelen-cardiovasculair/","https://hartvaat.nl/kennis/cardiometabool/diabetes-type-1-en-hart/"],"congress":"","summary_en":"Long-term follow-up of the BIOMArCS-2 Glucose Trial showed that intensive glucose regulation in hyperglycemic MI patients does not provide lasting cardiovascular benefit compared with standard care.","created":"2026-07-03T10:26:19Z","updated":"2026-07-03T13:25:39Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Langetermijnfollow-up van de BIOMArCS-2 Glucose Trial die intensieve glucoseregulatie vergeleek met standaardzorg bij patiënten met hyperglycemie en ACS. Onderzoekt of acute glucosecontrole langetermijnuitkomsten beïnvloedt.","abstract_original":""}